Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-11-22Sensoril® (Ashwagandha), an Immunomodulator and Anti-inflammatory Agent for Schizophrenia: A Parallel Group, Randomized Double Blind, and Placebo Controlled Study
-
CLINICAL_TRIALS study record update · 2017-11-21ClinicalTrials.gov study NCT00888693
-
CLINICAL_TRIALS study record update · 2017-11-14Evaluation of Metamemory in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-11-09A Proof-of Concept Trial of Galantamine and Memantine for Cognitive Impairments in Schizophrenia: Is the Combination Effective?
-
CLINICAL_TRIALS study record update · 2017-11-07Cognitive Remediation for Perceptual Deficits in Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-11-06Implementing Patient-Centered Decision Support for Mental Health
-
CLINICAL_TRIALS study record update · 2017-10-31Combined Oxytocin and CBSST for Social Function in People With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-10-26A Randomized Controlled Trial Comparing Joint Crisis Plans With Crisis Cards for People With Bipolar Disorders, Schizophrenia and Other Psychotic Disorders to Reduce Involuntary Admission and Coercive Measures.
-
CLINICAL_TRIALS study record update · 2017-10-19"MADOCS: Manual Dexterity and Oculomotor Control as Vulnerability Markers in Schizophrenia"
-
CLINICAL_TRIALS study record update · 2017-10-19A Phase II Randomised, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Four Orally Administrated Doses of BI 409306 During a 12-week Treatment Period in Patients With Schizophrenia on Stable Antipsychotic Treatment
-
CLINICAL_TRIALS study record update · 2017-10-19The Partners Genetics Collaborative Study of Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-10-12Clozapine Fixed Dose Steady State Plasma Levels and the Relationship to the Polymorphism of CYP1A2, CYP3A4, CYP3A5 and CYP2D6 in Clinically Stable Schizophrenic Adult Patients
-
CLINICAL_TRIALS study record update · 2017-10-12Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients
-
CLINICAL_TRIALS study record update · 2017-10-09Screening, Evaluation, Diagnosis, Treatment Optimization and Follow-up for Childhood Onset Psychotic Disorders
-
CLINICAL_TRIALS study record update · 2017-10-09Top Down Visual Information Processing in Schizophrenia Patients With Visual Hallucinations
-
CLINICAL_TRIALS study record update · 2017-10-06Internal Monitoring of Eye Movement in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-10-05Relating the 'Experienced Present' With the Mechanisms of Neuronal Function: A Comparative Study in Patients With Schizophrenia and Healthy Controls Using Psychophysical and Neurophysiological Methods
-
CLINICAL_TRIALS study record update · 2017-10-05Pain and Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-10-05Pilot Study of Atomoxetine To Enhance COgnition In Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-10-04Improving Outcomes for Individuals With Serious Mental Illness and Diabetes
-
CLINICAL_TRIALS study record update · 2017-09-29A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, 6-Week Study to Evaluate the Efficacy and Safety of TAK-063 in Subjects With an Acute Exacerbation of Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-09-29Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-09-29A Dose-response Study of Modafinil Effects on Cognition in Schizophrenia Patients.
-
CLINICAL_TRIALS study record update · 2017-09-27A Randomised Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Cognitive Enhancing Effect of GSK239512 in Stable Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2017-09-21Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia